Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-13

Clinical Trial Update: Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg) [NA]

View source ↗

Summary

A completed pharmacokinetic study comparing nicotine absorption from two NP2 variants (NP2-4mg and NP2-6mg) with nicotine lozenge 4mg and nicotine gum 4mg to as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NP2-4mg (nicotine)
  • NP2-6mg (nicotine)
  • Nicotine Gum 4mg (nicotine)
  • Nicotine Lozenge 4mg (nicotine)

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Tobacco Use | NA | Status: COMPLETED